Benjamin Jones

1.0k total citations
20 papers, 365 citations indexed

About

Benjamin Jones is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Benjamin Jones has authored 20 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Benjamin Jones's work include Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Benjamin Jones is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Benjamin Jones collaborates with scholars based in United States. Benjamin Jones's co-authors include Lawrence S. Lamb, Antonio Di Stasi, Frederick D. Goldman, Guru Sonpavde, Leonid Chepelev, Jonathan W. Goldman, Frank J. Rybicki, Edward B. Garon, Peter G. Pappas and Dennis J. Slamon and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Medicine.

In The Last Decade

Benjamin Jones

18 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Jones United States 9 226 95 94 77 62 20 365
Wen Zhu China 7 239 1.1× 117 1.2× 109 1.2× 92 1.2× 73 1.2× 13 396
Sarah Wright United Kingdom 10 274 1.2× 106 1.1× 171 1.8× 121 1.6× 126 2.0× 30 627
Carrie Yuen United States 7 284 1.3× 123 1.3× 163 1.7× 70 0.9× 102 1.6× 19 470
Laura Kummer Germany 7 198 0.9× 130 1.4× 105 1.1× 88 1.1× 46 0.7× 17 370
Royce Ma United States 8 233 1.0× 151 1.6× 108 1.1× 36 0.5× 77 1.2× 10 371
Aleksei Titov Russia 7 214 0.9× 147 1.5× 122 1.3× 61 0.8× 70 1.1× 13 368
Kotaro Miyao Japan 11 215 1.0× 90 0.9× 91 1.0× 85 1.1× 73 1.2× 34 377
Rachel Grosser United States 6 356 1.6× 193 2.0× 123 1.3× 112 1.5× 57 0.9× 12 540
Zachary E. Tano United States 6 343 1.5× 118 1.2× 116 1.2× 125 1.6× 80 1.3× 30 468
Ruimin Hong China 9 283 1.3× 75 0.8× 127 1.4× 60 0.8× 72 1.2× 29 355

Countries citing papers authored by Benjamin Jones

Since Specialization
Citations

This map shows the geographic impact of Benjamin Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Jones more than expected).

Fields of papers citing papers by Benjamin Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Jones. The network helps show where Benjamin Jones may publish in the future.

Co-authorship network of co-authors of Benjamin Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Jones. A scholar is included among the top collaborators of Benjamin Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Jones. Benjamin Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, S. Lloyd, et al.. (2025). Assessing the Psychosocial Impact of Expressive Writing on Adults With Spinal Cord Injury: Qualitative Study. JMIR Formative Research. 9. e71162–e71162.
2.
Jones, Benjamin, et al.. (2024). Identifying CNS infections in transplantation and immunomodulatory therapy. Therapeutic Advances in Infectious Disease. 11. 2028533272–2028533272.
3.
Jones, Benjamin, et al.. (2024). Cardioneural ablation—the first case series without the use of fluoroscopy. Journal of Interventional Cardiac Electrophysiology. 68(2). 433–439. 1 indexed citations
4.
Gerstenecker, Adam, Mark Bolding, Lawrence Ver Hoef, et al.. (2023). Effects of a brief HIIT intervention on cognitive performance in older women. GeroScience. 46(1). 1371–1384. 1 indexed citations
5.
Blanchard, Christina T., Lorie M. Harper, Lindsay S. Robbins, et al.. (2023). Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy. Obstetrics and Gynecology. 142(5). 1179–1188. 1 indexed citations
6.
Ravi, Prashanth, et al.. (2022). Medical 3D Printing Dimensional Accuracy for Multi-pathological Anatomical Models 3D Printed Using Material Extrusion. Journal of Digital Imaging. 35(3). 613–622. 20 indexed citations
7.
Hu‐Lieskovan, Siwen, Aaron Lisberg, Jesse M. Zaretsky, et al.. (2019). Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(16). 5061–5068. 56 indexed citations
8.
Paluri, Ravi Kumar, et al.. (2019). Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 83(3). 551–559. 8 indexed citations
9.
Noor, Zorawar S., Jonathan W. Goldman, William Lawler, et al.. (2019). Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer. Lung Cancer. 135. 104–109. 10 indexed citations
10.
Lisberg, Aaron, Amy L. Cummings, Jonathan W. Goldman, et al.. (2018). A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC.. Journal of Clinical Oncology. 36(15_suppl). 9014–9014. 5 indexed citations
11.
Paluri, Ravi Kumar, et al.. (2018). Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2591–2591. 1 indexed citations
12.
13.
Jones, Benjamin, et al.. (2016). Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients. Cancer Chemotherapy and Pharmacology. 78(3). 509–515. 4 indexed citations
14.
Jordan, Stephen J., et al.. (2016). Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab. Open Forum Infectious Diseases. 3(1). ofw038–ofw038. 20 indexed citations
15.
Paluri, Ravi Kumar, Charity J. Morgan, David Mooney, et al.. (2015). Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the Bladder. Clinical Genitourinary Cancer. 13(5). 469–475. 6 indexed citations
16.
Sonpavde, Guru, Benjamin Jones, Joaquim Bellmunt, Toni K. Choueiri, & Cora N. Sternberg. (2014). Future Directions and Targeted Therapies in Bladder Cancer. Hematology/Oncology Clinics of North America. 29(2). 361–376. 16 indexed citations
17.
Jones, Benjamin, Lawrence S. Lamb, Frederick D. Goldman, & Antonio Di Stasi. (2014). Improving the safety of cell therapy products by suicide gene transfer. Frontiers in Pharmacology. 5. 254–254. 179 indexed citations
18.
Jones, Benjamin, et al.. (2014). Danger on a Half Shell: Vibrio vulnificus Septicemia. The American Journal of Medicine. 128(5). 475–476. 5 indexed citations
19.
Jones, Benjamin, et al.. (2014). A 22-Year-Old Woman with Abdominal Pain. Journal of General Internal Medicine. 29(7). 1074–1078. 8 indexed citations
20.
Dugger, Kari J., et al.. (2013). Moderate aerobic exercise alters migration patterns of antigen specific T helper cells within an asthmatic lung. Brain Behavior and Immunity. 34. 67–78. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Zhu Breakdown of academic impact, for papers by Sarah Wright Breakdown of academic impact, for papers by Carrie Yuen Breakdown of academic impact, for papers by Laura Kummer Breakdown of academic impact, for papers by Royce Ma Breakdown of academic impact, for papers by Aleksei Titov Breakdown of academic impact, for papers by Kotaro Miyao Breakdown of academic impact, for papers by Rachel Grosser Breakdown of academic impact, for papers by Zachary E. Tano Breakdown of academic impact, for papers by Ruimin Hong
Rankless by CCL
2026